Skip to content

iRhythm Holdings, Inc. IRTC Acquired in-process research and development expenses

Acquired in-process research and development expenses at other companies

iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
$296K0.0%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$29.15M+46.3%
Minerals Technologies logo
Minerals TechnologiesMTX
$6.1M+5.2%
Belden logo
BeldenBDC
$30.09M+5.9%
ServiceTitan, Inc. logo
ServiceTitan, Inc.TTAN
$684.75K
Organon logo
OrganonOGN
$10M0.0%

Other financials

Income statement

See full
Revenue$199.4M+25.7%
Gross profit$141.4M+29.4%
Operating income-$16.2M+50.3%
Net income-$13.9M+54.6%
EPS (diluted)-$0.43+55.7%

Balance sheet

See full
Cash & equivalents$248.5M-35.2%
Total debt$79.0M-10.5%
Total equity$161.2M+86.0%
Total assets$1.0B+8.7%

Cash flow

See full
Operating cash flow-$26.2M-232%
CapEx$6.9M-26.7%
Free cash flow-$33.1M-91.1%

Valuation

See full
Market cap$3.62B+16.0%

Profitability

See full
Gross margin71%+1.6pp
Operating margin-5.5%-2.2pp
Net margin-7.3%-3.1pp
FCF margin2.4%

Returns & leverage

See full
Return on equity-53.1%-17.4pp
Debt / equity0.5×-0.5×
Current ratio5.2×-0.5×

Where this comes from

Reported directly by iRhythm Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff.

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's acquired in-process research and development expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's acquired in-process research and development expenses?
iRhythm Holdings, Inc. (IRTC) reported acquired in-process research and development expenses of $296K in Q1 2026.
How has iRhythm Holdings, Inc. 's acquired in-process research and development expenses changed year-over-year?
iRhythm Holdings, Inc. 's acquired in-process research and development expenses decreased by 0.0% year-over-year, from $296K to $296K.
What does acquired in-process research and development expenses mean?
This metric represents the costs associated with acquiring in-process research and development projects through business combinations or asset acquisitions. It reflects capital allocated toward external innovation and intellectual property that has not yet reached technological feasibility. Monitoring this expense helps investors understand the company's strategy for inorganic growth and its commitment to expanding its product pipeline through strategic acquisitions.